Revance Therapeutics shares owned by CIBC Global Asset Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by CIBC Global Asset Management
from 13F filings
Historical chart of CIBC Global Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by CIBC Global Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by CIBC Global Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $3.7M | 327k | 11.47 |
| 2023-06-30 | $5.9M | 233k | 25.31 |
| 2023-03-31 | $7.3M | 227k | 32.21 |
| 2022-12-31 | $7.6M | 412k | 18.46 |
| 2022-09-30 | $14M | 501k | 27.00 |
| 2022-03-31 | $9.2M | 471k | 19.50 |
| 2021-12-31 | $8.1M | 498k | 16.32 |
More positions owned by CIBC Global Asset Management
View all positions for CIBC Global Asset Management